Study | Country Study period |
Population source | Exposure definition | Non-exposure definition | Sample size | Rmk |
---|---|---|---|---|---|---|
Shapira, 2020 |
Israel 2013 - 2015 |
Patients treated for Nausea and vomiting in pregnancy (NVP) admitted in emergency room at 1st and/ or 2nd trimester. | Patients who were exposed to granisetron. |
unexposed, sick
Patients without exposure to granisetron. |
100 / 108 | Cases diagnosed with chromosomal aberrations and cases of pregestational diabetes were excluded from the study. |
Study | Country Study period |
Case | Control | Sample size | Rmk |
---|---|---|---|---|---|
Fejzo, 2015 |
USA 2007 - 2011 |
Children exposed to hyperemesis gravidarum (HG) with neurodevelopmental delay. | Children exposed to hyperemesis gravidarum (HG) with a good outcome. | 138 / 174 | Main analysis: case control related to the impact of the HG illness (treated or not) on child outcomes. Then impact of 37 medications/treatments (1st and/or 2nd trimester) on child outcome was investigated (none was significantly associated with delay). |
Fejzo, 2013 |
USA 2007 - 2011 |
Pregnant women with hyperemesis gravidarum (HG) who have negative outcomes (birth weight less than 10%, perinatal mortality, and/or preterm birth (<37 weeks)). | Pregnant women with hyperemesis gravidarum (HG) who have positive outcomes. | 43 / 211 | Comparison of use of various medications/treatments in the two groups (43 HG participants with an adverse outcome compared to 211 HG participants with a good outcome). |